Exenatide as a long-acting GLP-1 receptor agonist, plays an important role in the treatment of type 2 diabetes mellitus. It helps patients improve glycemic control by promoting insulin secretion and glucose control.
Basic Information
English Name: Exenatide
CAS Number: 141758-74-9
Molecular Formula: C184H282N50O60S
Molecular Weight: 4186.6
Pharmacological Action
Exenatide is a GLP-1 receptor agonist that mimics the activity of the mammalian incretin hormone GLP-1, promoting insulin secretion and glucose control. By activating the GLP-1 receptor, Exenatide enhances insulin secretion, inhibits glucagon release, and thereby improves glycemic control.
Indications
Indications: Exenatide injection (Byetta) is indicated for improving glycemic control in patients with type 2 diabetes mellitus who have not achieved adequate glycemic control with metformin, sulfonylureas, or a combination of metformin and sulfonylureas.
